RACK1 Regulates G₁/S Progression by Suppressing Src Kinase Activity

REFERENCES

• Abe, K., Rossman K. L., Liu B., Ritola K. D., Chiang D., Campbell S. L., Burridge K., and Der C. J.. 2000. Vav2 is an activator of Cdc42, Rac1, and RhoA. J. Biol. Chem. 275:10141–10149.
   PubMed Web of Science ®Google Scholar
• Abram, C. L., and Courtneidge S. A.. 2000. Src family tyrosine kinases and growth factor signaling. Exp. Cell Res. 254:1–13.
   PubMed Web of Science ®Google Scholar
• Amati, B., Alevizopoulos K., and Vlach J.. 1998. Myc and the cell cycle. Front. Biosci. 3:D250–D268.
   PubMed Web of Science ®Google Scholar
• Barone, M. V., and Courtneidge S. A.. 1995. Myc but not Fos rescue of PDGF signalling block caused by kinase-inactive Src. Nature 378:509–512.
   PubMed Web of Science ®Google Scholar
• Blake, R. A., Broome M. A., Liu X., Wu J., Gishizky M., Sun L., and Courtneidge S. A.. 2000. SU6656, a selective Src family kinase inhibitor, used to probe growth factor signaling. Mol. Cell. Biol. 20:9018–9027.
   PubMed Web of Science ®Google Scholar
• Bowman, T., Broome M. A., Sinibaldi D., Wharton W., Pledger W. J., Sedivy J. M., Irby R., Yeatman T., Courtneidge S. A., and Jove R.. 2001. Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis. Proc. Natl. Acad. Sci. USA 13:7319–7324.
   Google Scholar
• Bromberg, J. F., Wrzeszczynska M. H., Devgan G., Zhao Y., Pestell R. G., Albanese C., and Darnell J. E., Jr. 1999. Stat3 as an oncogene. Cell 98:295–303.
   PubMed Web of Science ®Google Scholar
• Broome, M. A., and Courtneidge S. A.. 2000. No requirement for src family kinases for PDGF signaling in fibroblasts expressing SV40 large T antigen. Oncogene 19:2867–2869.
   PubMed Web of Science ®Google Scholar
• Bustelo, X. R. 2000. Regulatory and signaling properties of the Vav family. Mol. Cell. Biol. 20:1461–1477.
   PubMed Web of Science ®Google Scholar
• Cartwright, C. A., Eckhart W., Simon S., and Kaplan P. L.. 1987. Cell transformation by pp60c-src mutated in the carboxyl-terminal regulatory domain. Cell 49:83–91.
   PubMed Web of Science ®Google Scholar
• Chang, B. Y., Conroy K. B., Machleder E. M., and Cartwright C. A.. 1998. RACK1, a receptor for activated C kinase and a homolog of the β subunit of G proteins, inhibits activity of Src tyrosine kinases and growth of NIH 3T3 cells. Mol. Cell. Biol. 18:3245–3256.
   PubMed Web of Science ®Google Scholar
• Chang, B. Y., Chiang M., and Cartwright C. A.. 2001. The interaction of Src and RACK1 is enhanced by PKC activation and tyrosine phosphorylation of RACK1. J. Biol. Chem. 276:20346–20356.
   PubMed Web of Science ®Google Scholar
• Chang, B. Y., Harte R., and Cartwright C. A.. 2002. RACK1: a novel substrate for the Src protein-tyrosine kinase. Oncogene 21:7619–7629.
   PubMed Web of Science ®Google Scholar
• Cheng, M. G., Olivier P., Diehl J. A., Fero M., Roussel M. F., Roberts J. M., and Sherr C. J.. 1999. The p21Cip1 and p27Kip1 CDK ′inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18:1571–1583.
   PubMed Web of Science ®Google Scholar
• Chiariello, M., Marinissen M. J., and Gutkind J. S.. 2001. Regulation of c-myc expression by PDGF through Rho GTPases. Nat. Cell Biol. 3:580–586.
   PubMed Web of Science ®Google Scholar
• Coqueret, O. 2003. New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol. 13:65–70.
   PubMed Web of Science ®Google Scholar
• Coso, O. A., Chiariello M., Yu J. C., Teramoto H., Crespo P., Xu N., Miki T., and Gutkind J. S.. 1995. The small GTP-binding proteins Rac1 and Cdc42 regulate activity of the JNK/SAPK signaling pathway. Cell 81:1137–1146.
   PubMed Web of Science ®Google Scholar
• Courtneidge, S. A. 2002. Role of Src in signal transduction pathways. Biochem. Soc. Trans. 30:11–17.
   PubMedGoogle Scholar
• Crespo, P., Schuebel K. E., Ostrom A. A., Gutkind J. S., and Bustelo X. R.. 1997. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 385:169–172.
   PubMed Web of Science ®Google Scholar
• Diaz-Meco, M. T., Municio M. M., Frutos S., Sanchez P., Lozano J., Sanz L., and Moscat J.. 1996. The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C. Cell 86:777–786.
   PubMed Web of Science ®Google Scholar
• Donjerkovic, D., and Scott D. W.. 2000. Regulation of the G1 phase of the mammalian cell cycle. Cell Res. 1:1–16.
   Google Scholar
• Dorn, G. W., and Mochly-Rosen D.. 2002. Intracellular transport mechanisms of signal transducers. Annu. Rev. Physiol. 64:407–429.
   PubMed Web of Science ®Google Scholar
• Eisenman, R. N., and Cooper J. A.. 1995. Signal transduction. Beating a path to Myc. Nature 378:438–439.
   PubMed Web of Science ®Google Scholar
• el-Deiry, W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W., and Vogelstein B.. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817–825.
   PubMed Web of Science ®Google Scholar
• Fero, M. L., et al. 1998. The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature 396:177–180.
   PubMed Web of Science ®Google Scholar
• Furstoss, O., Manes G., and Roche S.. 2002. Cyclin E and cyclin A are likely targets of Src for PDGF-induced DNA synthesis in fibroblasts. FEBS Lett. 526:82–86.
   PubMed Web of Science ®Google Scholar
• Hay, J. C., Hirling H., and Scheller R. H.. 1996. Mammalian vesicle trafficking proteins of the endoplasmic reticulum and Golgi apparatus. J. Biol. Chem. 271:5671–5679.
   PubMedGoogle Scholar
• He, T. C., Sparks A. B., Rago C., Hermeking H., Zawel L., da Costa L. T., Morin P. J., Vogelstein B., and Kinzler K. W.. 1998. Identification of c-MYC as a target of the APC pathway. Science 281:1509–1512.
   PubMed Web of Science ®Google Scholar
• Hermanto, U., Zong C. S., Li W. W., and Wang L.-H.. 2002. RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix. Mol. Cell. Biol. 22:2345–2365.
   PubMed Web of Science ®Google Scholar
• Huang, T. S., Kuo M. L., Shew J. Y., Chou Y. W., and Yang W. K.. 1996. Distinct p53-mediated G1/S checkpoint responses in two NIH3T3 subclone cells following treatment with DNA-damaging agents. Oncogene 13:625–632.
   PubMedGoogle Scholar
• Klinghoffer, R. A., Sachsenmaier C., Cooper J. A., and Soriano P.. 1999. Src family kinases are required for integrin but not PDGFR signal transduction. EMBO J. 18:2459–2471.
   PubMed Web of Science ®Google Scholar
• Kmiecik, T. E., and Shalloway D.. 1987. Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation. Cell 49:65–73.
   PubMed Web of Science ®Google Scholar
• Lipsich, L. A., Lewis A. J., and Brugge J. S.. 1983. Isolation of monoclonal antibodies that recognize the transforming proteins of avian sarcoma viruses. J. Virol. 48:352–360.
   PubMedGoogle Scholar
• Mochly-Rosen, D. 1995. Localization of protein kinases by anchoring proteins: a theme in signal transduction. Science 268:247–251.
   PubMed Web of Science ®Google Scholar
• Moyers, J. S., Bouton A. H., and Parsons S. J.. 1993. The sites of phosphorylation by protein kinase C and an intact SH2 domain are required for the enhanced response to β-adrenergic agonists in cells overexpressing c-src. Mol. Cell. Biol. 13:2391–2400.
   PubMedGoogle Scholar
• Nasi, S., Ciarapica R., Jucker R., Rosati J., and Soucek L.. 2001. Making decisions through Myc. FEBS Lett. 490:153–162.
   PubMed Web of Science ®Google Scholar
• Park, J., and Cartwright C. A.. 1995. Src activity increases and Yes activity decreases during mitosis of human colon carcinoma cells. Mol. Cell. Biol. 15:2374–2382.
   PubMedGoogle Scholar
• Paul, C. P., Good P. D., Winer I., and Engelke D. R.. 2002. Effective expression of small interfering RNA in human cells. Nat. Biotechnol. 20:505–508.
   PubMed Web of Science ®Google Scholar
• Pawson, T. 2004. Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems. Cell 116:191–203.
   PubMed Web of Science ®Google Scholar
• Piwnica-Worms, H., Saunders K. B., Roberts T. M., Smith A. E., and Cheng S. H.. 1987. Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src. Cell 49:75–82.
   PubMed Web of Science ®Google Scholar
• Reynolds, A. B., Vila J., Lansing T. J., Potts W. M., Weber M. J., and Parsons J. T.. 1987. Activation of the oncogenic potential of the avian cellular Src protein by specific structural alteration of the carboxyl terminus. EMBO J. 6:2359–2364.
   PubMed Web of Science ®Google Scholar
• Riley, D., Carragher N. O., Frame M. C., and Wyke J. A.. 2001. The mechanism of cell cycle regulation by v-Src. Oncogene 20:5941–5950.
   PubMed Web of Science ®Google Scholar
• Robinson, M. J., and Cobb M. H.. 1997. Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 9:180–186.
   PubMed Web of Science ®Google Scholar
• Roche, S., Koegl M., Barone M. V., Roussel M. F., and Courtneidge S. A.. 1995. DNA synthesis induced by some but not all growth factors requires Src family protein tyrosine kinases. Mol. Cell. Biol. 15:1102–1109.
   PubMed Web of Science ®Google Scholar
• Servitja, J.-M., Marinissen M. J., Sodhi A., Bustelo X. R., and Gutkind J. S.. 2003. Rac1 function is required for Src-induced transformation. J. Biol. Chem. 278:34339–34346.
   PubMedGoogle Scholar
• Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672–1677.
   PubMed Web of Science ®Google Scholar
• Sherr, C. J., and Roberts J. M.. 1999. CDK inhibitors: positive and negative regulators of G1 phase progression. Genes Dev. 13:1501–1512.
   PubMed Web of Science ®Google Scholar
• Simon, A. R., Vikis H. G., Stewart S., Fanburg B. L., Cochran B. H., and Guan K. L.. 2000. Regulation of STAT3 by direct binding to the Rac1 GTPase. Science 290:144–147.
   PubMed Web of Science ®Google Scholar
• Sinibaldi, D., Wharton W., Turkson J., Bowman T., Pledger W. J., and Jove R.. 2000. Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling. Oncogene 19:5419–5427.
   PubMed Web of Science ®Google Scholar
• Slingerland, J., and Pagano M.. 2000. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J. Cell. Physiol. 183:10–17.
   PubMed Web of Science ®Google Scholar
• Thomas, S. M., and Brugge J. A.. 1997. Cellular functions regulated by Src family kinases. Annu. Rev. Cell Dev. Biol. 13:513–609.
   PubMed Web of Science ®Google Scholar
• Turkson, J., Bowman T., Adnane J., Zhang Y., Djeu J. Y., Sekharam M., Frank D. A., Holzman L. B., Wu J., Sebti S., and Jove R.. 1998. Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol. Cell. Biol. 18:2545–2552.
   PubMed Web of Science ®Google Scholar
• Twamley-Stein, G. M., Pepperkok R., Ansorge W., and Courtneidge S. A.. 1993. The Src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH 3T3 cells. Proc. Natl. Acad. Sci. USA 90:7696–7700.
   PubMed Web of Science ®Google Scholar
• Van Aelst, L., and D'Souza-Schorey C.. 1997. Rho GTPases and signaling networks. Genes Dev. 11:2295–2322.
   PubMed Web of Science ®Google Scholar
• Welsh, C. F., Roovers K., Villanueva J., Liu Y., Schwartz M. A., and Assoian R. K.. 2001. Timing of cyclin D1 expression within G1 phase is controlled by Rho. Nat. Cell Biol. 3:950–957.
   PubMed Web of Science ®Google Scholar